Carregant...
Modelling the cost-effectiveness of catch-up ‘MenB’ (Bexsero) vaccination in England
We assessed the cost-effectiveness of offering catch-up vaccination with Bexsero against meningococcal disease to children too old to receive the vaccine under the recently introduced infant programme. Offering catch-up vaccination to increasingly older children is less economically attractive becau...
Guardat en:
| Publicat a: | Vaccine |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier Science
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5418563/ https://ncbi.nlm.nih.gov/pubmed/27923519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2016.11.076 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|